The Global Health Observatory
Explore a world of health data
SDG Target 3.b Support the research and development of vaccines and medicines for the communicable and non‑communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines
Over the past decade, routine immunization services for children have expanded greatly, especially in regions where coverage of some vaccination programmes had been low, such as the WHO Africa and South-East Asia Regions. However, some of those immunization services have been affected by COVID-19.
DTP3 (third dose of diphtheria, tetanus toxoid and pertussis-containing vaccine) immunization coverage among one-year-olds worldwide decreased from 86% in 2019 to 81% in 2021. This resulted in 25 million children missing out on vaccination, 6 million more than in 2019 and the highest number since 2009
Global coverage of MCV2 (second-dose of measles-containing vaccine) immunization remained steady in 2019–2021 (at about 70%). Global coverage of PCV3 (third dose of pneumococcal-containing vaccines) immunization more than quadrupled between 2010 (when it was about 11%) and 2021 as newer vaccines are reaching those who need them more rapidly than before. However, this progress was also disrupted in 2020-2021.
Summary findings
Proportion of the target population covered by all vaccines included in their national programme
GHO WHS4_100 DTP3 DPT3 Diphtheria tetanus toxoid pertussis MAP
Total net official development assistance to medical research and basic health sectors
Data and estimates : SDG Target 3.b
-
Total net official development assistance to medical research and basic health sectors per capita (US$), by recipient country
-
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)
-
Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%)
-
Pneumococcal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%)
-
Girls aged 15 years old that received the recommended doses of HPV vaccine
-
Proportion of health facilities with a core set of relevant essential medicines available and affordable on a sustainable basis
Related indicators
-
BCG immunization coverage among 1-year-olds (%) -
Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%) -
Hib (Hib3) immunization coverage among 1-year-olds (%) -
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) -
Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) -
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%) -
Neonates protected at birth against neonatal tetanus (PAB) (%) -
Pneumococcal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%) -
Polio (Pol3) immunization coverage among 1-year-olds (%) -
Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%) -
Proportion of vaccination cards seen (%) (Immunization) -
Girls aged 15 years old that received the recommended doses of HPV vaccine
-
Congenital Rubella Syndrome - number of reported cases -
Diphtheria - number of reported cases -
Japanese encephalitis - number of reported cases -
Measles - number of reported cases -
Mumps - number of reported cases -
Neonatal tetanus - number of reported cases -
Pertussis - number of reported cases -
Poliomyelitis - number of reported cases -
Rubella - number of reported cases -
Total tetanus - number of reported cases -
Yellow fever - number of reported cases
Related metadata
Related health topic
Related factsheet